24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Entera
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:12
Israel’s tech exports hit a record but foreign owners are claiming more of the gains
16:55
Full list of Israeli high-tech funding rounds in 2026
16:52
Sayeret Matkal veterans raise $22 million to teach the world English with AI
15:11
SentinelOne CEO sells $2.29 million in shares as stock closes in on its yearly high
More stories
Buzz
Most popular
Daily
Weekly
1
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
2
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
3
Oracle’s AI transformation gets more expensive as layoffs continue
4
OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million
5
Oracle begins another round of layoffs as $2.8 billion restructuring plan expands
More news
Entera
4 stories about Entera
Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal
12.12.18
|
Lilach Baumer
The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments
Entera Bio Gives Nasdaq IPO Another Shot
21.05.18
|
Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
CTech’s Daily Israeli Tech News Roundup
08.01.18
|
CTech
Israeli investment house to open crypto unit. A closer look at the first company funded by Koch’s new venture capital firm. Intuition Robotics expands funding round, nabbing Samsung as an investor.
For the Fourth Time, Entera Bio Tries for Nasdaq IPO
08.01.18
|
Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter